Test dye imaging during surgery for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether using a special imaging dye during surgery can help surgeons better manage parts of the bowel during operations for ovarian cancer. It may help guide whether a low anterior rectosigmoid resection and reconnection (anastomosis) are needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have ovarian, fallopian tube, or primary peritoneal cancer (new or recurring).
- You are scheduled for debulking or cytoreductive surgery.
- Your team thinks you may need a low anterior rectosigmoid resection during that surgery.
- You give consent and are enrolled before your operation starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special dye, injected during surgery, can help doctors see if a bowel connection is healing well. It is for women having gynecologic cancer surgery that includes removing part of the bowel.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This study tests using a special fluorescent dye (ICG) during surgery to help surgeons see and remove colon cancer more clearly. The dye highlights blood vessels and tissue, which may help ensure all cancer is removed safely.
This trial tests a special dye called indocyanine green to help surgeons see blood flow during surgery to remove part of the colon. If you have colorectal disease and need surgery, this could help make your operation safer.
This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.
This study tests whether using a special dye during surgery helps people with stage III colorectal cancer stay cancer-free longer. The dye, called indocyanine green (ICG), makes tumors and lymph nodes glow under a special camera, helping surgeons remove them more precisely.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.